期刊文献+

CD24表达在乳腺浸润性导管癌中的意义 被引量:1

Expression and significance of CD24 and Ki67 in breast invasive ductal carcinoma
原文传递
导出
摘要 目的探讨乳腺浸润性导管癌组织中CD24的表达与肿瘤增殖和侵袭的关系。方法应用免疫组织化学方法检测142例乳腺浸润性导管癌组织中CD24、Ki67的表达,与其他临床病理参数进行比较;分析57例CD24阳性病例中导管内癌成分与浸润性成分CD24的表达;根据ER和c-erbB-2表达分组,比较各组间CD24的表达。结果在乳腺浸润性导管癌中,CD24的表达在患者年龄分组、肿瘤大小及PR、c-erbB-2的表达上差异无统计学意义,而在有无淋巴结转移、组织学分级、临床分期、ER及Ki67的表达上差异有统计学意义;且CD24表达等级与Ki67的表达等级之间呈正相关。在合并DCIS的IDC中导管内癌成分和浸润性成分CD24的表达差异无统计学意义。在不同的ER和c-erbB-2表达组间CD24的表达差异有统计学意义。结论CD24的高表达在乳腺癌的增殖和侵袭中起重要作用。检测CD24和Ki67有助于乳腺癌病情的预后判断。 Objective To investigate the expression and significance of CD24 and Ki67 in breast invasive ductal carcinoma and explore the roles of CD24 and Ki67 in cell proliferation and invasiveness. Methods The expression of CD24 and Ki67 in the tissues from 142 patients with invasive ductal carcinoma was detected by using immunohistochemistry. The expression levels were compared with clinicopathologic parameters and observed in intraductal carcinoma and invasive carcinoma. The CD24 expression significance was analyzed in each group according to the expression of ER and c-erbB-2. Results CD24 expression wasn' t associated with the patient' s age, tumor size, PR and c-erbB-2 status as well as histopathology. There were correlations between the CD24 expression and node status, grade, clinical stage, ER as well as Ki67 level. The rank of the CD24 expression was positively related with Ki67. There was significant difference in CD24 level between various groups based on the expression of ER and c-erbB-2. Conclusion The over expression of CD24 acts as an important role in the proliferation and invasiveness of breast carcinoma. The determination of CD24 and Ki67 is helpful to predicting the prognosis of breast carcinoma.
作者 刘宁 牛昀
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2008年第12期1596-1599,共4页 Chinese Journal of Experimental Surgery
基金 长江学者创新团队资助项目(IRT0743)
关键词 乳腺癌 CD24 KI67 Breast carcinoma CD24 Ki67
  • 相关文献

参考文献17

  • 1冯玉梅,李晓青,孙保存,曹旭晨,顾林,牛昀,郝希山.基于乳腺原发癌基因表达谱的预后分子分型研究[J].中华肿瘤杂志,2006,28(12):900-906. 被引量:3
  • 2Lim SC. CD24 and human carcinima: tumor biological aspects. Biomed Pharmacother,2005,59 : 351-354.
  • 3Kristiansen G, Sammar M, Altevogt P. Tumor biological aspects of CD24,a mucin-like adhesion molecule. J Mol Histol,2004,35:255- 262.
  • 4Lim SC, Oh SH. The role of CD24 in various human epithelial neoplasias. Pathol Res Pratt,2005,201:479-486.
  • 5Tavassoli FA, Devilee P. The WHO classification of tumors of the breast and female genital organs ( M ). Editors IARC Press. Lyon, 2003 : 10-112.
  • 6Matt van de Rijn, Perou CM. Expression of cytokeratins 17 and 5 i- dentifies a group of breast carcinomas with poor clinical outcome. Am J Pathol,2002,161 : 1991-1996.
  • 7Bircan S,Kkapucuoglu N,Baspinar S,et al. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast;an immunohistochemistry-based pilot study. Pathol Res Pract, 2006,202 : 569-576.
  • 8Borsig L, Wong R, Hynes RO, et al. Synergistic effects of L-and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc Natl Acad Sci USA ,2002,99:2193-2198.
  • 9Borsig L. Selectins facilitate carcinoma metastasis and heparin can prevent them. News Physiol Sci ,2004,19 : 16-21.
  • 10Banmann P, Cremers N, Kroese F, et al. CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis. Cancer Res ,2005,65 : 10783-10793.

二级参考文献18

  • 1郝希山,冯玉梅,张亮,李晓青,牛昀,肖春花,孙保存.采用单引物扩增法标记的基因芯片技术筛选乳腺原发癌与淋巴结转移癌的差异表达基因[J].中华医学杂志,2005,85(6):385-390. 被引量:24
  • 2Hartigan JA,Wong MA.A k-means clustering algorithm.Applied statistics,1979,28:100-108.
  • 3Zeeberg BR,Feng W,Wang G,et al.GoMiner:a resource for biological interpretation of genomic and proteomic data.Genome Biol,2003,4:R28.
  • 4Goldhirsch A,Glick JH,Gelber RD,et al.Meeting highlights:International Consensus Panel on the Treatment of Primary Breast Cancer.J Natl Cancer Inst,1998,90:1601-1608.
  • 5van't Veer LJ,Dai H,van de Vijver MJ,et al.Gene expression profiling predicts clinical outcome of breast cancer.Nature,2002,415:530-536.
  • 6Braun S,Vogl FD,Naume B,et al.A pooled analysis of bone marrow micrometastasis in breast cancer.N Engl J Med,2005,353:793 -802.
  • 7van de Vijver MJ,He YD,van't Veer LJ,et al.A gene-expression signature as a predictor of survival in breast cancer.N Engl J Med,2002,347:1999-2009.
  • 8Wang Y,Klijn JG,Zhang Y,et al.Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.Lancet,2005,365:671-679.
  • 9Gruvberger S,Ringner M,Chen Y,et al.Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns.Cancer Res,2001,61:5979-5984.
  • 10West M,Blanchette C,Dressman H,et al.Predicting the clinical status of human breast cancer by using gene expression profiles.Proc Natl Acad Sci U S A,2001,98:11462-11467.

共引文献2

同被引文献12

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1368
  • 2柯玉华,胡胜,付小玉.乳腺干细胞和乳腺癌[J].中国肿瘤,2006,15(8):526-528. 被引量:3
  • 3Oliveira LR, Jeffrey SS, Ribeiro - Silva A. Stem cells in human breast cancer [ J ]. Histol Histopathol,2010,25 (3) :371 - 385.
  • 4Nguyen NP, Almeida FS, Chi A, et al. Molecular biology of breast cancer stem cells: potential clinical applications [ J]. Cancer Treat Rev,2010,36(6) :485 -491.
  • 5Abraham BK, Fritz P, McClellan M, et al. Prevalence of CD44 + / CD24 -/low cells in breast cancer may not be associated with clin- ical outcome but may favor distant metastasis [ J ]. Clin CancerRes.2005.11(3):1154 -1159.
  • 6Paltian V, Alldinger S, Baumgairtner W, et al. Expression of CD44 in canine mammary tumours [ J]. J Comp Pathol,2009, 141 (4) :237 -247.
  • 7Madjd Z, Mehrjerdi AZ, Sharifi AM, et al. CIM4 + cancer cells express higher levels of the anti - apoptotic protein Bcl - 2 in breast tumours [J]. Cancer lmmun,2009 ,9 :4.
  • 8Wang SJ, Wreesmann VB, Bourguignon LY. Association of CD44 V3containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node me- tastasis in head and neck cancer [ J ]. Head Neck, 2007,29 (6) :550 -558.
  • 9Lee H J, Choe G, Jheon S, ct al. CD24, a novel cancer biomark- er, predicting disease -free survival of nonsmall cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification [J]. J Thorac 0ncol,2010,5(5) :649 -657.
  • 10吕新全,Zhenhe Suo,马长路,徐珂佳,刘羿杉,李惠翔.CD44^+/CD24^-细胞在乳腺癌组织及细胞系中的数量与分布[J].中华病理学杂志,2009,38(7):441-444. 被引量:7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部